The roles of lipids and nucleic acids in HIV-1 assembly
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
During HIV-1 assembly, precursor Gag (PrGag) proteins are delivered to plasma membrane (PM) assembly sites, where they are triggered to oligomerize and bud from cells as immature virus particles. The delivery and triggering processes are coordinated by the PrGag matrix (MA) and nucleocapsid (NC) domains. Targeting of PrGag proteins to membranes enriched in cholesterol and phosphatidylinositol-4,5-bisphosphate (PI[4,5]P2) is mediated by the MA domain, which also has been shown to bind both RNA and DNA. Evidence suggests that the nucleic-acid-binding function of MA serves to inhibit PrGag binding to inappropriate intracellular membranes, prior to delivery to the PM. At the PM, MA domains putatively trade RNA ligands for PI(4,5)P2 ligands, fostering high-affinity membrane binding. Triggering of oligomerization, budding, and virus particle release results when NC domains on adjacent PrGag proteins bind to viral RNA, leading to capsid (CA) domain oligomerization. This process leads to the assembly of immature virus shells in which hexamers of membrane-bound MA trimers appear to organize above interlinked CA hexamers. Here, we review the functions of retroviral MA proteins, with an emphasis on the nucleic-acid-binding capability of the HIV-1 MA protein, and its effects on membrane binding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Göttlinger, H. G., Sodroski, J. G., & Haseltine, W. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5781 · Cited by 841
HIV-1 Gag proteins: diverse functions in the virus life cycle
Freed, E. O. (1998) · Virology · doi:10.1006/viro.1998.9398 · Cited by 717 · cited 3×
“During the maturation process, cleavage of HIV-1 PrGag by the viral protease (PR) generates the mature myristoylated matrix (MA) protein as well as capsid (CA), nucleocapsid (NC), p6 and two spacer peptides, Sp1 and Sp2 (Swanstrom and Wills, 1997; Freed, 1998).”
BackgroundMethodInfluentialPhosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane
Ono, A., Ablan, S. D., Lockett, S. J., Nagashima, K., & Freed, E. O. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405596101 · Cited by 553
Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly
Saad, J. S., Miller, J., Tai, J., Kim, A., Ghanam, R. H., & Summers, M. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602818103 · Cited by 545 · cited 8×
“Some of these residues (residues 33, 73, 76, and 79) previously were shown to contribute to the PI(4,5)P2 binding site (Figure 5; Saad et al., 2006).”
BackgroundMethodInfluentialHill, C. P., Worthylake, D., Bancroft, D. P., Christensen, A. M., & Sundquist, W. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.3099 · Cited by 473 · cited 4×
“Matrix structures for the following retroviruses have been determined: HIV- 1 (Massiah et al., 1994; Hill et al., 1996; Tang et al., 2004; Saad et al., 2006, 2007), HIV-2 (Saad et al., 2008), SIV (Rao et al., 1995), human T-lymphotropic virus 2 (HTLV-2; Christensen et al., 1996), BLV (Matthews et…”
BackgroundInfluentialCampbell, S., & Rein, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2270-2279.1999 · Cited by 293 · cited 1×
“Retroviral genomes encode PrGag polyproteins that are necessary and sufficient for assembly and release of virus-like particles (VLP) from cells (Campbell and Vogt, 1995; Coffin et al., 1997; Swanstrom and Wills, 1997; Campbell and Rein, 1999; Gross et al., 2000; Campbell et al., 2001).”
BackgroundChan, R., Uchil, P. D., Jin, J., Shui, G., Ott, D. E., Mothes, W., & Wenk, M. R. (2008) · Journal of Virology · doi:10.1128/jvi.00981-08 · Cited by 282 · cited 2×
“MA–PI(4,5)P2 interactions also have been observed for MLV, MPMV, and EIAV (Stansell et al., 2007; Chan et al., 2008; Chen et al., 2008; Hamard-Peron et al., 2010).”
BackgroundThree-dimensional structure of the human immunodeficiency virus type 1 matrix protein
Massiah, M. A., Starich, M. R., Paschall, C., Summers, M. F., Christensen, A. M., & Sundquist, W. I. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1719 · Cited by 271
Chukkapalli, V., Hogue, I. B., Boyko, V., Hu, W.-S., & Ono, A. (2008) · Journal of Virology · doi:10.1128/jvi.01614-07 · Cited by 268 · cited 5×
“…overexpression of polyphosphoinositide 5-phosphatase IV was shown to reduce HIV-1 and MLV assembly efficiency, resulting in the delivery of viral proteins to intracellular compartments (Ono et al., 2004; Chan et al., 2008; Chukkapalli et al., 2008; Hamard-Peron et al., 2010; Inlora et al., 2011).”
BackgroundResultInfluentialChukkapalli, V., Oh, S. J., & Ono, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908661107 · Cited by 229 · cited 8×
“This could be plausible if the MA affinity for RNA were between its affinity for PI(4,5)P2 and that for other phospholipids, so that RNA binding could protect MA from binding to inappropriate membranes (Alfadhli et al., 2009b, 2011; Chukkapalli et al., 2010, 2013; Chukkapalli and Ono, 2011).”
BackgroundResultInfluentialDirect interaction between the envelope and matrix proteins of HIV-1
Cosson, P. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00964.x · Cited by 211
Burniston, M. T., Cimarelli, A., Colgan, J., Curtis, S. P., & Luban, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8527-8540.1999 · Cited by 190 · cited 2×
“In support of these studies, it has been shown by Burniston et al. (1999) that the basic residues of the HIV-1 MA domain contribute to Gag–Gag interactions in the presence of RNA and the absence of the NC domain, indicating that the basic residues on MA play a role in RNA binding (Burniston et al.,…”
BackgroundCrystal structure of SIV matrix antigen and implications for virus assembly
Rao, Z., Belyaev, A. S., Fry, E., Roy, P., Jones, I. M., & Stuart, D. I. (1995) · Nature · doi:10.1038/378743a0 · Cited by 183 · cited 4×
“…have been determined: HIV- 1 (Massiah et al., 1994; Hill et al., 1996; Tang et al., 2004; Saad et al., 2006, 2007), HIV-2 (Saad et al., 2008), SIV (Rao et al., 1995), human T-lymphotropic virus 2 (HTLV-2; Christensen et al., 1996), BLV (Matthews et al., 1996), M-PMV (Conte et al., 1997), Rous…”
InfluentialAnalysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids
Alfadhli, A., Still, A., & Barklis, E. (2009) · Journal of Virology · doi:10.1128/jvi.01197-09 · Cited by 145 · cited 12×
“This could be plausible if the MA affinity for RNA were between its affinity for PI(4,5)P2 and that for other phospholipids, so that RNA binding could protect MA from binding to inappropriate membranes (Alfadhli et al., 2009b, 2011; Chukkapalli et al., 2010, 2013; Chukkapalli and Ono, 2011).”
BackgroundMethodResultSelf-citationConformation of the HIV-1 Gag Protein in Solution
Datta, S. A. K., Curtis, J. E., Ratcliff, W., Clark, P. K., Crist, R. M., Lebowitz, J., Krueger, S., & Rein, A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.073 · Cited by 145
Cellular proteins detected in HIV‐1
Ott, D. E. (2008) · Reviews in Medical Virology · doi:10.1002/rmv.570 · Cited by 141 · cited 2×
“REVIEW ARTICLE published: 28 May 2014 doi: 10.3389/fmicb.2014.00253 The roles of lipids and nucleic acids in HIV-1 assembly”
BackgroundMethodInfluentialMolecular determinants that regulate plasma membrane association of HIV-1 Gag
Chukkapalli, V., & Ono, A. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.015 · Cited by 129 · cited 4×
“Complementary studies by Ono and co-workers indicated that RNase treatment of Gag in vitro translation extracts reduced the selectivity of Gag binding for PI(4,5)P2 (Chukkapalli et al., 2010, 2013; Chukkapalli and Ono, 2011).”
BackgroundInfluentialDalton, A. K., Ako-Adjei, D., Murray, P. S., Murray, D., & Vogt, V. M. (2007) · Journal of Virology · doi:10.1128/jvi.02757-06 · Cited by 118
Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein
Luban, J., & Goff, S. P. (1991) · Journal of Virology · doi:10.1128/jvi.65.6.3203-3212.1991 · Cited by 108 · cited 2×
“These viruses are HIV-1 (Luban and Goff, 1991; Bukrinsky et al., 1993; Von Schwedler et al., 1994;; Lochrie et al., 1997; Miller et al., 1997; Reil et al., 1998; Haffar et al., 2000; Purohit et al., 2001; Ott et al., 2005; Hearps et al., 2008; Alfadhli et al., 2009b, 2011; Cai et al., 2010;…”
BackgroundSaad, J. S., Ablan, S. D., Ghanam, R. H., Kim, A., Andrews, K., Nagashima, K., Soheilian, F., Freed, E. O., & Summers, M. F. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.027 · Cited by 95 · cited 6×
“…to membrane binding is the myristyl group found in most retroviral MAs, including HIV-1 (Gottlinger et al., 1989; Bryant and Ratner, 1990; Spearman et al., 1994), HIV2 (Saad et al., 2008), MLV (Henderson et al., 1983), M-PMV (Schultz and Oroszlan, 1983), and HTLV (Ootsuyama et al., 1985).”
BackgroundInfluentialMatrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding
Jones, C. P., Datta, S. A. K., Rein, A., Rouzina, I., & Musier-Forsyth, K. (2011) · Journal of Virology · doi:10.1128/jvi.01809-10 · Cited by 94 · cited 3×
“Consistent observations by Jones et al. (2011), showed that both MA and NC PrGag domains can bind nucleic acids, and that binding of MA to inositol phosphate (IP) derivatives, which resemble the PI(4,5)P2 head group, alters the association of PrGag to nucleic acids.”
BackgroundMethodHamard-Peron, E., Juillard, F., Saad, J. S., Roy, C., Roingeard, P., Summers, M. F., Darlix, J.-L., Picart, C., & Muriaux, D. (2010) · Journal of Virology · doi:10.1128/jvi.01134-09 · Cited by 92
HIV-1 matrix protein binding to RNA
Alfadhli, A., McNett, H., Tsagli, S., Bächinger, H. P., Peyton, D. H., & Barklis, E. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.063 · Cited by 87 · cited 14×
“In vitro competition binding experiments also showed that a soluble PI(4,5)P2 mimic (PIPC8) reduced Sel25 binding to MA, whereas a soluble PS mimic did not; while FA competition data indicated that PIPC8 reduced MA–RNA binding levels to a greater extent than did the PS mimic (Alfadhli et al., 2011).”
BackgroundMethodSelf-citationIt is Rous sarcoma virus protein P12 and not P19 that binds tightly to Rous sarcoma virus RNA
Méric, C., Darlix, J.-L., & Spahr, P.-F. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90396-6 · Cited by 80
Chukkapalli, V., Inlora, J., Todd, G. C., & Ono, A. (2013) · Journal of Virology · doi:10.1128/jvi.00075-13 · Cited by 76
Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein
Choi, G., Park, S., Choi, B., Hong, S., Lee, J., Hunter, E., & Rhee, S. S. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5431-5437.1999 · Cited by 61
Stansell, E., Apkarian, R., Haubova, S., Diehl, W. E., Tytler, E. M., & Hunter, E. (2007) · Journal of Virology · doi:10.1128/jvi.00657-07 · Cited by 59 · cited 7×
“MA–PI(4,5)P2 interactions also have been observed for MLV, MPMV, and EIAV (Stansell et al., 2007; Chan et al., 2008; Chen et al., 2008; Hamard-Peron et al., 2010).”
BackgroundMethodInfluentialChristensen, A. M., Massiah, M. A., Turner, B. G., Sundquist, W. I., & Summers, M. F. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0700 · Cited by 59
Ott, D. E., Coren, L. V., & Shatzer, T. (2009) · Journal of Virology · doi:10.1128/jvi.00099-09 · Cited by 37
Cited by
Global changes in the RNA binding specificity of HIV-1 Gag regulate virion genesis
Kutluay, S. B., Zang, T., Blanco-Melo, D., Powell, C., Jannain, D., Errando, M., & Bieniasz, P. D. (2014) · Cell · doi:10.1016/j.cell.2014.09.057 · Cited by 257
“MA Binds to Particular tRNAs Although the aforementioned Gag-RNA binding events were assumed to involve the NC domain of Gag, there are numerous reports that MA can interact with viral or cellular RNAs (reviewed in Alfadhli and Barklis, 2014).”
PI(4,5)P2-binding effector proteins for vesicle exocytosis
Martin, T. F. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.017 · Cited by 124
“The intact phosphoinositide PI(4,5)P2 plays a critical role in most if not all cellular events associated with the plasma membrane including regulated vesicle exocytosis [17], constitutive vesicle exocytosis [18], endocytosis [19], F-actin assembly [20], cell adhesion [21], phagocytosis [22], viral budding [23], enzym…”
BackgroundUnderstanding retroviral life cycle and its genomic RNA packaging
Chameettachal, A., Mustafa, F., & Rizvi, T. A. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167924 · Cited by 41
RNA and Nucleocapsid Are Dispensable for Mature HIV-1 Capsid Assembly
Mattei, S., Flemming, A., Anders-Össwein, M., Kräusslich, H.-G., Briggs, J. A. G., & Müller, B. (2015) · Journal of Virology · doi:10.1128/jvi.00750-15 · Cited by 24
Metadata
- Authors
- Alfadhli, A., & Barklis, E.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2014-05-28
- Volume
- 5
- Pages
- 253-253
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2150717831
- Cited by
- 35
- References
- 29
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.